Etiology of Monoclonal Gammopathy and Multiple Myeloma in Patients With Gaucher Disease

What is the Purpose of this Study?

This study focuses on individuals who have Gaucher disease, a condition in which fatty substances accumulate in certain organs. The purpose of the study is to identify factors in the blood of Gaucher patients that could lead to the development of monoclonal gammopathy (MG) or multiple myeloma (MM). MG and MM are more common in Gaucher patients, for unknown reasons. MG is a non-cancerous condition in which the body makes an abnormal protein (paraprotein). MM is a cancer that forms in a type of white blood cell called a plasma cell. This study will collect blood samples to examine the function of B cells, Gaucher biomarkers, and specific genes involved in B cell function. B cells are a type of white blood cell that play an important part in the body’s immune system. Researchers hope that by analyzing B cells, they can identify clues to the development of MG or MM in Gaucher patients.


Eligibility

Not Available


Where can I participate?

  • Cedars-Sinai Cancer at Beverly Hills (THO) : Saba Mukarram
  • Cedars-Sinai Cancer at SOCC : Saba Mukarram



What is the full name of this clinical trial?

THO-19-001: Etiology of Monoclonal Gammopathy and Multiple Myeloma in Patients with Gaucher Disease

Study Details
Disease Type/Condition

Multiple Myeloma

Principal Investigator

Rosenbloom, Barry

Co-Investigators

Jeremy Lorber

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

STUDY00000264


How do I learn more about this study?
Name

Saba Mukarram

Phone
+1 310-231-2181
Email
MukarramS@cshs.org
Study Detail
Disease Type/Condition

Multiple Myeloma

Principal Investigator

Rosenbloom, Barry

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

IIT2020-25-ROSENBLOOM-264


Contact
Name

Saba Mukarram

Phone
+1 310-231-2181
Email
MukarramS@cshs.org